Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1988 Feb;59(2):175–183. doi: 10.1136/hrt.59.2.175

Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction.

C de Zwaan 1, G M Willems 1, F Vermeer 1, J Res 1, F W Verheugt 1, A van der Laarse 1, M L Simoons 1, J Lubsen 1, W T Hermens 1
PMCID: PMC1276981  PMID: 3342158

Abstract

The activity of alpha-hydroxybutyrate dehydrogenase, creatine kinase, creatine kinase MB and aspartate aminotransferase was measured on serial plasma samples from patients with acute myocardial infarction. The study was part of a multicentre randomised trial of the effect of thrombolytic treatment in the acute phase of acute myocardial infarction. The applicability and comparability of enzyme tests for the estimation of myocardial injury were studied in 76 control patients and 74 patients treated with streptokinase. Treatment with streptokinase caused a considerable acceleration of enzyme release after acute myocardial infarction, both in patients with persistent coronary occlusion and in those with successful reperfusion. But this changed pattern of enzyme release did not affect the rate of enzyme elimination from plasma or the released proportions of different enzymes. Thus the assessment of infarct size by measurement of these enzyme activities can also be applied to patients treated with streptokinase. Moreover, the enzymes measured in the present study are all equally valid markers of myocardial injury.

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar F. W., Vermeer F., de Zwaan C., Ramentol M., Braat S., Simoons M. L., Hermens W. T., van der Laarse A., Verheugt F. W., Krauss X. H. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute. Am J Cardiol. 1987 Jan 1;59(1):6–13. doi: 10.1016/s0002-9149(87)80060-7. [DOI] [PubMed] [Google Scholar]
  2. Bleifeld W., Mathey D., Hanrath P., Buss H., Effert S. Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics. Circulation. 1977 Feb;55(2):303–311. doi: 10.1161/01.cir.55.2.303. [DOI] [PubMed] [Google Scholar]
  3. Erhardt L. R. Clinical and pathological observations in different types of acute myocardial infarction. Acta Med Scand Suppl. 1974;560:1–78. [PubMed] [Google Scholar]
  4. Fung A. Y., Rabkin S. W. Beneficial effects of streptokinase on left ventricular function after myocardial reoxygenation and reperfusion following global ischemia in the isolated rabbit heart. J Cardiovasc Pharmacol. 1984 May-Jun;6(3):429–435. doi: 10.1097/00005344-198405000-00009. [DOI] [PubMed] [Google Scholar]
  5. Ganz W., Geft I., Maddahi J., Berman D., Charuzi Y., Shah P. K., Swan H. J. Nonsurgical reperfusion in evolving myocardial infarction. J Am Coll Cardiol. 1983 May;1(5):1247–1253. doi: 10.1016/s0735-1097(83)80136-3. [DOI] [PubMed] [Google Scholar]
  6. Grande P., Hansen B. F., Christiansen C., Naestoft J. Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation. 1982 Apr;65(4):756–764. doi: 10.1161/01.cir.65.4.756. [DOI] [PubMed] [Google Scholar]
  7. HORT W., DACANALIS S. UNTERSUCHUNGEN AN RATTENHERZEN NACH TEMPORAERER UNTERBINDUNG DER LINKEN KRANZARTERIE. Virchows Arch Pathol Anat Physiol Klin Med. 1965 Mar 31;339:61–71. [PubMed] [Google Scholar]
  8. Hackel D. B., Reimer K. A., Ideker R. E., Mikat E. M., Hartwell T. D., Parker C. B., Braunwald E. B., Buja M., Gold H. K., Jaffe A. S. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation. 1984 Nov;70(5):824–835. doi: 10.1161/01.cir.70.5.824. [DOI] [PubMed] [Google Scholar]
  9. Hearse D. J., Humphrey S. M., Chain E. B. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol. 1973 Aug;5(4):395–407. doi: 10.1016/0022-2828(73)90030-8. [DOI] [PubMed] [Google Scholar]
  10. Hermens W. T., Willems G. M., Davids H. A., Hollaar L., van der Laarse A. Enzymatic assessment of myocardial injury after infarction or cardiac surgery. Is isoenzyme analysis required? Clin Chim Acta. 1986 May 15;156(3):235–246. doi: 10.1016/0009-8981(86)90067-7. [DOI] [PubMed] [Google Scholar]
  11. KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
  12. Kwong T. C., Fitzpatrick P. G., Rothbard R. L. Activities of some enzymes in serum after therapy with intracoronary streptokinase in acute myocardial infarction. Clin Chem. 1984 May;30(5):731–734. [PubMed] [Google Scholar]
  13. Körtge P., Praetorius F., Schneider B., Heckner F., van de Loo J., Pezold F. A., Poliwoda H., Schmutzler R., Zekorn D. Zur thrombolytischen Therapie des frischen Herzinfarktes. 3. Zusammenfassende Beurteillung unter Einschluss der Enzymauswertung. Dtsch Med Wochenschr. 1967 Sep 1;92(35):1546–1551. doi: 10.1055/s-0028-1106003. [DOI] [PubMed] [Google Scholar]
  14. Puckett S. W., Digerness S. B., Bowdon H. R., Rogers W. J., Rackley C. E. Direct effects of streptokinase on the isolated rat myocardium. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1120–1123. [PubMed] [Google Scholar]
  15. RAISZ L. G., SCHEER R. L. Studies on the renal concentrating mechanism. II. Effect of small acute changes in solute excretion. J Clin Invest. 1959 Jan 1;38(1 Pt 1):1–7. doi: 10.1172/JCI103778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. ROSALKI S. B., WILKINSON J. H. Reduction of alpha-ketobutyrate by human serum. Nature. 1960 Dec 24;188:1110–1111. doi: 10.1038/1881110a0. [DOI] [PubMed] [Google Scholar]
  17. Rentrop K. P. Thrombolytic therapy in patients with acute myocardial infarction. Circulation. 1985 Apr;71(4):627–631. doi: 10.1161/01.cir.71.4.627. [DOI] [PubMed] [Google Scholar]
  18. Roberts R., Ambos H. D., Sobel B. E. Estimation of infarct size with MB rather than total CK. Int J Cardiol. 1983;2(5-6):479–492. doi: 10.1016/0167-5273(83)90149-3. [DOI] [PubMed] [Google Scholar]
  19. Roberts R., Henry P. D., Sobel B. E. An improved basis for enzymatic estimation of infarct size. Circulation. 1975 Nov;52(5):743–754. doi: 10.1161/01.cir.52.5.743. [DOI] [PubMed] [Google Scholar]
  20. Rosalki S. B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967 Apr;69(4):696–705. [PubMed] [Google Scholar]
  21. Schreiber F., Eulitz H. J. Streptokinasebehandlung des frischen Herzinfarkts. Med Klin. 1973 May 4;68(18):592–597. [PubMed] [Google Scholar]
  22. Schröder R., Biamino G., von Leitner E. R., Linderer T., Brüggemann T., Heitz J., Vöhringer H. F., Wegscheider K. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation. 1983 Mar;67(3):536–548. doi: 10.1161/01.cir.67.3.536. [DOI] [PubMed] [Google Scholar]
  23. Shell W. E., Kjekshus J. K., Sobel B. E. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest. 1971 Dec;50(12):2614–2625. doi: 10.1172/JCI106762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Simoons M. L., Serruys P. W., van den Brand M., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Bär F., de Zwaan C., van der Laarse A. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol. 1986 Apr;7(4):717–728. doi: 10.1016/s0735-1097(86)80329-1. [DOI] [PubMed] [Google Scholar]
  25. Simoons M. L., Serruys P. W., vd Brand M., Bär F., de Zwaan C., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Vermeer F. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985 Sep 14;2(8455):578–582. doi: 10.1016/s0140-6736(85)90584-7. [DOI] [PubMed] [Google Scholar]
  26. Van der Laarse A., Dijkshoorn N. J., Hollaar L., Caspers T. The (iso)enzyme activities of lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase, creatine kinase and aspartate aminotransferase in human myocardial biopsies and autopsies. Clin Chim Acta. 1980 Jul 1;104(3):381–391. doi: 10.1016/0009-8981(80)90397-6. [DOI] [PubMed] [Google Scholar]
  27. Vatner S. F., Baig H., Manders W. T., Maroko P. R. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest. 1978 Apr;61(4):1048–1056. doi: 10.1172/JCI109004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vermeer F., Simoons M. L., Bär F. W., Tijssen J. G., van Domburg R. T., Serruys P. W., Verheugt F. W., Res J. C., de Zwaan C., van der Laarse A. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation. 1986 Dec;74(6):1379–1389. doi: 10.1161/01.cir.74.6.1379. [DOI] [PubMed] [Google Scholar]
  29. Verstraete M. The difficulty of appraisal of streptokinase treatment of myocardial infarction. Angiologica. 1971;8(1):43–56. [PubMed] [Google Scholar]
  30. Willems G. M., Muijtjens A. M., Lambi F. H., Hermens W. T. Estimation of circulatory parameters in patients with acute myocardial infarction. Significance for calculation of enzymatic infarct size. Cardiovasc Res. 1979 Oct;13(10):578–587. doi: 10.1093/cvr/13.10.578. [DOI] [PubMed] [Google Scholar]
  31. Willems G. M., Visser M. P., Krill M. T., Hermens W. T. Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymes. Cardiovasc Res. 1982 Mar;16(3):120–131. doi: 10.1093/cvr/16.3.120. [DOI] [PubMed] [Google Scholar]
  32. Willems G. M., van der Veen F. H., Huysmans H. A., Flameng W., de Meyere R., van der Laarse A., van der Vusse G. J., Hermens W. T. Enzymatic assessment of myocardial necrosis after cardiac surgery: differentiation from skeletal muscle damage, hemolysis, and liver injury. Am Heart J. 1985 Jun;109(6):1243–1252. doi: 10.1016/0002-8703(85)90346-1. [DOI] [PubMed] [Google Scholar]
  33. Witteveen S. A., Hemker H. C., Hollaar L., Hermens W. T. Quantitation of infarct size in man by means of plasma enzyme levels. Br Heart J. 1975 Aug;37(8):795–803. doi: 10.1136/hrt.37.8.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Würzburg U., Hennrich N., Lang H., Prellwitz W., Neumeier D., Knedel M. Bestimmung der Aktivität von Creatinkinase MB im Serum unter Verwendung inhibierender Antikörper. Klin Wochenschr. 1976 Apr 15;54(8):357–360. doi: 10.1007/BF01469790. [DOI] [PubMed] [Google Scholar]
  35. van der Laarse A., Hermens W. T., Hollaar L., Jol M., Willems G. M., Lemmers H. E., Liem A. H., Souverijn J. H., Oudhof J. H., de Hooge J. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels. Am Heart J. 1984 Feb;107(2):248–260. doi: 10.1016/0002-8703(84)90372-7. [DOI] [PubMed] [Google Scholar]
  36. van der Laarse A., Vermeer F., Hermens W. T., Willems G. M., de Neef K., Simoons M. L., Serruys P. W., Res J., Verheugt F. W., Krauss X. H. Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. Am Heart J. 1986 Oct;112(4):672–681. doi: 10.1016/0002-8703(86)90460-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES